Search Results
Results found for "Dr. Ben Myers"
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Addex Therapeutics To Release Full-Year 2021 Financial Results And Host Conference Call On March 10
Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology, will provide a business
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
3D was used to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
strategic priorities, including pursuing additional collaborations across our portfolio,” said Tim Dyer
- Adhesion GPCR Consortium Newsletter - May 2024
postdoctoral training, I joined one of the labs that participated in Latrophilins’ discovery, the lab of Dr
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
Dr. Rößler P, Mayer D, Tsai CJ, Veprintsev DB, Schertler GFX, Gossert AD.
- Glyco-sulfo hotspots in the chemokine receptor system
which have an established role in chemokine gradients and oligomerization (Deshauer C et al. 2015; Dyer
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
.; Iyer, M. R.; Cinar, R.; Coffey, N.
